Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 451-500 of 672 result(s).
CYDY CytoDyn Inc
12/11/2020 10:11:56 PM
I am in no way disagreeing with you (1)
CYDY CytoDyn Inc
12/11/2020 9:47:36 PM
You mean the front line health care
CYDY CytoDyn Inc
12/11/2020 9:15:35 PM
The shorter version: https://www.md (4)
CYDY CytoDyn Inc
12/11/2020 8:08:41 PM
For those interested, one of the mo (4)
CYDY CytoDyn Inc
12/11/2020 11:56:33 AM
The samples do not exist and the te (2)
CYDY CytoDyn Inc
12/09/2020 10:43:54 PM
Ask NP tomorrow.
CYDY CytoDyn Inc
12/09/2020 10:25:46 PM
This is not a hit job or a short at (3)
CYDY CytoDyn Inc
12/09/2020 9:48:11 PM
It is not a spoof. No way in the le (1)
RLFTF Mondobiotech Holding AG Basel
11/17/2020 9:59:03 AM
Where is he speaking?
CYDY CytoDyn Inc
11/11/2020 6:35:26 PM
Hi everybody, I thought I should sh (5)
CYDY CytoDyn Inc
11/10/2020 9:39:16 PM
Well said there could be a small bu
CYDY CytoDyn Inc
11/10/2020 6:14:58 PM
Well I may look at this in a differ (6)
RLFTF Mondobiotech Holding AG Basel
11/10/2020 2:12:34 PM
Oh I have a feeling EUA is near... (2)
RLFTF Mondobiotech Holding AG Basel
11/10/2020 1:42:03 PM
As a physician, well stated, the o/ (2)
CYDY CytoDyn Inc
11/08/2020 5:26:29 PM
Off label with current P&T oversite
CYDY CytoDyn Inc
11/08/2020 5:23:36 PM
Wallerian degradation?
RLFTF Mondobiotech Holding AG Basel
11/07/2020 10:04:18 AM
The drug's huge potential will be t (2)
RLFTF Mondobiotech Holding AG Basel
11/05/2020 1:20:59 PM
Phase bio suspended the trial due t (2)
CYDY CytoDyn Inc
11/04/2020 7:55:30 PM
Absolutely correct, don't believe t (1)
CYDY CytoDyn Inc
11/02/2020 11:34:00 PM
Whether right or wrong, look at the (1)
CYDY CytoDyn Inc
11/02/2020 11:25:47 PM
NeuroRx has already received EAP in
CYDY CytoDyn Inc
11/02/2020 8:04:02 PM
Yes Rub, your interpretations are j
CYDY CytoDyn Inc
11/01/2020 9:56:02 PM
From what I researched 18.2 cash on (1)
CYDY CytoDyn Inc
10/31/2020 8:37:30 PM
I did my best to get back to the DM (2)
CYDY CytoDyn Inc
10/31/2020 11:39:41 AM
To all of those who sent DM's to me (2)
CYDY CytoDyn Inc
10/30/2020 9:54:10 PM
More importantly we only talk scien (4)
CYDY CytoDyn Inc
10/30/2020 9:50:27 PM
Yes I spent two great days with him (9)
CYDY CytoDyn Inc
10/27/2020 12:03:42 PM
Just providing factual information, (1)
CYDY CytoDyn Inc
10/27/2020 8:52:31 AM
There is lab panel for long haulers
CYDY CytoDyn Inc
10/26/2020 9:41:09 PM
Leronilmab is not being considered
CYDY CytoDyn Inc
10/26/2020 9:38:28 PM
I agree but I think a doubled board
CYDY CytoDyn Inc
10/26/2020 10:37:05 AM
The case for not un blinding sectio (4)
CYDY CytoDyn Inc
10/12/2020 8:11:34 PM
Yes he has already been spending ti
CYDY CytoDyn Inc
10/08/2020 3:42:46 PM
Nice review; but also the soluble A
CYDY CytoDyn Inc
10/05/2020 7:19:09 PM
It was not mono-therapy for POTUS.
CYDY CytoDyn Inc
10/05/2020 6:00:04 PM
I don't think so. I am keeping my p
CYDY CytoDyn Inc
10/05/2020 4:07:53 PM
What I posted was a guideline, not
CYDY CytoDyn Inc
10/05/2020 4:06:09 PM
Well to all that speculated that PO (1)
CYDY CytoDyn Inc
10/05/2020 12:30:43 PM
Recommendations for Patients with C
RLFTF Mondobiotech Holding AG Basel
10/05/2020 12:21:53 PM
Maybe my post was misunderstood, I (1)
CYDY CytoDyn Inc
10/04/2020 8:01:40 PM
From "up to date": Patients with se
CYDY CytoDyn Inc
10/04/2020 7:41:39 PM
Yes
CYDY CytoDyn Inc
10/04/2020 7:36:03 PM
Dex vs hydrocortisone is based on d
CYDY CytoDyn Inc
10/04/2020 6:47:38 PM
That was in the severe to critical,
CYDY CytoDyn Inc
10/04/2020 4:00:35 PM
Based on the RECOVER study in the U
CYDY CytoDyn Inc
10/04/2020 3:53:30 PM
No from WSU school of Medicine 1986
CYDY CytoDyn Inc
10/04/2020 1:46:32 PM
Journal of Microbiology, Immunology
CYDY CytoDyn Inc
10/04/2020 12:04:39 PM
The author told me within a month, (1)
CYDY CytoDyn Inc
10/04/2020 11:57:45 AM
No
CYDY CytoDyn Inc
10/04/2020 11:35:39 AM
I meant to say is WILL be available
Go to page:
  • << First
  • < Previous
  • 9
  • 10
  • Next >

Recent Articles

  • Investors Can Take Action in Hims & Hers Health, Inc. Case
  • Understanding Quishing: The New Threat of QR Code Scams
  • GeneDx Holdings Corp. Investors Pursue Class Action Claims
  • Mark Cuban's Business Tips to Achieve Entrepreneurial Success
  • United Imaging Introduces Innovative Medical Imaging Solutions
  • Investor Alert: Designer Brands Inc. Securities Inquiry After 2025 Results
  • John Brennan's Stark Warning: Political Tactics and History
  • Revolutionizing Internet Connectivity: Inside Starlink's Vision
  • Navigating Retirement: Choices, Health Coverage, and Opportunities
  • Understanding the Risks of Sharing Back-to-School Photos
  • Critical Updates for Reckitt Benckiser Group PLC Investors
  • Investors Outcry: Join the Lockheed Martin Securities Class Action
  • Investors Take Action: Join the Sable Offshore Securities Case
  • Slate Truck: Budget-Friendly EV Picks Up Speed with New Model
  • Kiyosaki on Trump's Cryptocurrency Vision for America
  • Robert Kiyosaki on Trump's Vision for Crypto Dominance
  • Stock Stars of the Week: Insights into Recent Gains
  • Take Action If You've Lost Over $100K in 3D Systems
  • Updates on Class Action Suit Against Novo Nordisk Investors
  • Bitcoin Swift's Stage 3 Presale: Unprecedented Yield Opportunities
  • Join the Class Action Against PepGen Securities Fraud Now
  • Sarepta Investors Encouraged to Join Legal Action for Justice
  • Hangzhou Strengthens Global Connections Through Cultural Ties
  • Investors Encouraged to Join Rocket Pharmaceuticals Class Action
  • Market Insights: Declining Large Caps and Financial Impacts
  • Opportunity for Investors Affected by Petco Securities Fraud
  • Investors Can Lead 3D Systems Securities Fraud Class Action
  • Investors Urged to Join Alto Neuroscience Securities Lawsuit
  • Investors Urged to Join Lawsuit Against Vestis Corporation Today
  • Important Legal Updates for PepGen Inc. Investors Ahead
  • Investors Have a Unique Chance to Lead Fiserv's Securities Case
  • Investors Encouraged to Join the Centene Securities Fraud Case
  • HashJ Unveils User-Friendly XRP Contracts Amid Market Surge
  • Tech Giants' Earnings Insight Amid Economic Concerns
  • Investors Can Lead Legal Action Against Hims Securities Fraud
  • Investors Can Take Action in the iRobot Class Action Suit
  • J.M. Smucker Co. Under Scrutiny: Investment Concerns Arise
  • Hims & Hers Legal Situation: Understanding Your Options
  • Sarepta Therapeutics Faces Legal Challenges Over Elevidys Risks
  • Legal Considerations for RxSight, Inc. Investors Amidst Stock Decline
  • Michael Owen Partners with GK8 for iGaming Expansion Success
  • HashJ Expands Accessibility for XRP Investors with New Contracts
  • Trice Contracting Inc. Expands Services for Historic Preservation
  • Revolutionary Weight Loss Pill Offers New Hope for Obesity
  • Exploring the Future of Internet Connectivity with Starlink
  • Seize the Moment: Participate in Reckitt Benckiser Class Action
  • Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site